These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36163295)

  • 1. Is the practice of using oversized organs for recipients with elevated pulmonary vascular resistance justified?
    Thangappan K; Zafar F; Ahmed HF; Greenberg JW; Ashfaq A; Hirsch R; Chin C; Lehenbauer D; O'Donnell A; Morales DLS
    J Thorac Cardiovasc Surg; 2023 Dec; 166(6):1766-1779. PubMed ID: 36163295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of donor-to-recipient weight ratio on survival after heart transplantation: analysis of the United Network for Organ Sharing Database.
    Patel ND; Weiss ES; Nwakanma LU; Russell SD; Baumgartner WA; Shah AS; Conte JV
    Circulation; 2008 Sep; 118(14 Suppl):S83-8. PubMed ID: 18824775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicted heart mass-based size matching among recipients with moderate pulmonary hypertension: Outcomes and sex effect.
    Shah M; Saeed O; Shin J; Murthy S; Sims DB; Vukelic S; Goldstein D; Forest SJ; Jorde UP; Patel SR
    J Heart Lung Transplant; 2020 Jul; 39(7):648-656. PubMed ID: 32085934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selecting oversized donor cardiac allografts for patients with pulmonary hypertension may be unnecessary.
    Kwon MH; Wong S; Kittleson M; Ardehali A; Laks H; Shemin RJ; Kobashigawa J
    Transplant Proc; 2014 Jun; 46(5):1497-501. PubMed ID: 24935319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female donor hearts can improve survival for male pediatric heart transplant recipients.
    Greenberg JW; Moore RA; Kulshrestha K; Lorts A; Perry T; Huang B; Chen C; Morales DLS; Zafar F
    Pediatr Transplant; 2023 Feb; 27(1):e14414. PubMed ID: 36261871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful use of undersized donors for orthotopic heart transplantation--with a caveat.
    Blackbourne LH; Tribble CG; Langenburg SE; Sinclair KN; Rucker GB; Chan BB; Spotnitz WD; Bergin JD; Kron IL
    Ann Thorac Surg; 1994 Jun; 57(6):1472-5; discussion 1475-6. PubMed ID: 8010789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of mechanical circulatory support on pediatric heart transplant candidates with elevated pulmonary vascular resistance.
    Thangappan K; Morales DLS; Vu Q; Lehenbauer D; Villa C; Wittekind S; Hirsch R; Lorts A; Zafar F
    Artif Organs; 2021 Jan; 45(1):29-37. PubMed ID: 32530089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of older donor age and survival after weight-matched pediatric heart transplantation.
    Westbrook TC; Morales DLS; Khan MS; Bryant R; Castleberry C; Chin C; Zafar F
    J Heart Lung Transplant; 2017 May; 36(5):554-558. PubMed ID: 28073609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of cardiac transplantation from live donors: the domino heart transplant.
    Anyanwu AC; Banner NR; Radley-Smith R; Khaghani A; Yacoub MH
    J Heart Lung Transplant; 2002 Sep; 21(9):971-5. PubMed ID: 12231367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Predicted Heart Mass-Based Donor-Recipient Size Matching on Transplant Outcomes.
    Gliozzi G; Loforte A; Mariani C; Cavalli GG; Botta L; Santamaria V; Tassi S; Martìn-Suarez S; Potena L; Pacini D
    Transplant Proc; 2022 Apr; 54(3):774-781. PubMed ID: 35279307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oversized donor heart transplantation-clinical experience with an underestimated problem.
    Kasturi S; Kumaran T; Shetty V; Punnen J; Subramanya S; Raghuraman B; Parachuri VR; Shetty DP
    Indian J Thorac Cardiovasc Surg; 2021 Nov; 37(6):631-638. PubMed ID: 34776661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Size Matching Using Predicted Heart Mass With Mortality in Heart Transplant Recipients With Obesity or High Pulmonary Vascular Resistance.
    Tao R; Hess TM; Kuchnia A; Hermsen J; Raza F; Dhingra R
    JAMA Netw Open; 2023 Jun; 6(6):e2319191. PubMed ID: 37351886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of predicted heart mass-based size matching on survival after heart transplantation in Korea: Analysis of the Korean Organ Transplant Registry.
    Yoon M; Oh J; Lee CJ; Park JJ; Cho HJ; Choi JO; Jung SH; Lee HY; Choi DJ; Kim JJ; Jeon ES; Kang SM
    J Heart Lung Transplant; 2022 Dec; 41(12):1751-1760. PubMed ID: 36216692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oversizing of donor hearts: beneficial or detrimental?
    Costanzo-Nordin MR; Liao YL; Grusk BB; O'Sullivan EJ; Cooper RS; Johnson MR; Siebold KM; Sullivan HJ; Heroux AH; Robinson JA
    J Heart Lung Transplant; 1991; 10(5 Pt 1):717-30. PubMed ID: 1958678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the New Pulmonary Hypertension Definition on Heart Transplant Outcomes: Expanding the Hemodynamic Risk Profile.
    Crawford TC; Leary PJ; Fraser CD; Suarez-Pierre A; Magruder JT; Baumgartner WA; Zehr KJ; Whitman GJ; Masri SC; Sheikh F; De Marco T; Maron BA; Sharma K; Gilotra NA; Russell SD; Houston BA; Ramu B; Tedford RJ
    Chest; 2020 Jan; 157(1):151-161. PubMed ID: 31446063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor Oversizing Results in Improved Survival in Patients with Left Ventricular Assist Device.
    Schumer EM; Black MC; Rogers MP; Trivedi JR; Birks EJ; Lenneman AJ; Cheng A; Slaughter MS
    ASAIO J; 2016; 62(5):571-7. PubMed ID: 27258226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension.
    Tedford RJ; Beaty CA; Mathai SC; Kolb TM; Damico R; Hassoun PM; Leary PJ; Kass DA; Shah AS
    J Heart Lung Transplant; 2014 Mar; 33(3):289-97. PubMed ID: 24462554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-existing elevated pulmonary vascular resistance: long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation.
    Tenderich G; Koerner MM; Stuettgen B; Mirow N; Arusoglu L; Morshuis M; Bairaktaris A; Minami K; Koerfer R
    J Cardiovasc Surg (Torino); 2000 Apr; 41(2):215-9. PubMed ID: 10901524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of "increased-risk" donor hearts on transplant outcomes: A propensity-matched analysis.
    Shudo Y; Cohen JE; Lingala B; He H; Zhu Y; Woo YJ
    J Thorac Cardiovasc Surg; 2019 Feb; 157(2):603-610. PubMed ID: 30669225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.